200
Participants
Start Date
March 22, 2021
Primary Completion Date
July 25, 2023
Study Completion Date
July 25, 2023
SGLT2 inhibitor, GLP-1 RA
"Immediate initiation of guideline-directed medical therapy. Will also immediately receive the same educational services provided in the Education-First intervention."
Education-First
For the first 2-months of their participation, patients in this arm will receive curated patient education, an alert to providers, provider education, and then after 2 months, be invited to participate in the remote clinic. The patient education would consist of curated video content and informational worksheets provided by email or secure patient messaging. Provider alerts would happen through notifying of a patient's eligibility for therapy.
Brigham and Women's Hospital, Boston
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Brigham and Women's Hospital
OTHER